Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nash

Showing results (521-530 of 609) with videos related to

Pageof 61
Sort By:
Molecular Cancer Therapeutics|October 20, 2021
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal CarcinomatosisChristopher S Chandler, Meghan M Bell, Sebastian K Chung, et al.
Kidney International|April 2, 2018
Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rateMorgan E Grams, Yingying Sang, Shoshana H Ballew, et al.
Developmental Cell|May 26, 2026
An appendiceal cancer organoid biobank identifies phenotypic evolution and druggable dependencies of peritoneal carcinomatosisAhmed Mahmoud, Christine Sukhwa, Michael Giarrizzo, et al.
Annals of Surgery|April 22, 2024
Association of Lateral Pelvic Lymph Nodes with Disease Recurrence and Organ Preservation in Patients with Distal Rectal Adenocarcinoma Treated with Total Neoadjuvant TherapyNathalie R A Beets, Floris S Verheij, Hannah Williams, et al.
Journal of Clinical Medicine|April 27, 2024
Oncologic Outcomes of Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma Initially Managed with ChemoradiationRoni Rosen, Felipe F Quezada-Diaz, Mithat Gönen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2019
Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 MutationsMarjorie G Zauderer, Gowtham Jayakumaran, Mariel DuBoff, et al.
Clinical and Translational Radiation Oncology|February 16, 2026
Late toxicity after peposertib-enhanced chemoradiation in rectal cancer patients managed with organ preservationW Zambare, R Ravella, C Li, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Paired primary-metastasis patient-derived organoids and mouse models identify phenotypic evolution and druggable dependencies of peritoneal metastasis from appendiceal cancerAhmed Mahmoud, Philip H Choi, Christine Sukhwa, et al.
Journal of Medicinal Chemistry|November 30, 2004
Identification of a small molecule nonpeptide active site beta-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteasesCraig A Coburn, Shawn J Stachel, Yue-Ming Li, et al.
JAMA Oncology|March 23, 2018
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal CancerAndrea Cercek, Campbell S D Roxburgh, Paul Strombom, et al.
Pageof 61

Showing results (521-530 of 609) with videos related to

Sort By:
Pageof 61
Molecular Cancer Therapeutics|October 20, 2021
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal CarcinomatosisChristopher S Chandler, Meghan M Bell, Sebastian K Chung, et al.
Kidney International|April 2, 2018
Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rateMorgan E Grams, Yingying Sang, Shoshana H Ballew, et al.
Developmental Cell|May 26, 2026
An appendiceal cancer organoid biobank identifies phenotypic evolution and druggable dependencies of peritoneal carcinomatosisAhmed Mahmoud, Christine Sukhwa, Michael Giarrizzo, et al.
Annals of Surgery|April 22, 2024
Association of Lateral Pelvic Lymph Nodes with Disease Recurrence and Organ Preservation in Patients with Distal Rectal Adenocarcinoma Treated with Total Neoadjuvant TherapyNathalie R A Beets, Floris S Verheij, Hannah Williams, et al.
Journal of Clinical Medicine|April 27, 2024
Oncologic Outcomes of Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma Initially Managed with ChemoradiationRoni Rosen, Felipe F Quezada-Diaz, Mithat Gönen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2019
Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 MutationsMarjorie G Zauderer, Gowtham Jayakumaran, Mariel DuBoff, et al.
Clinical and Translational Radiation Oncology|February 16, 2026
Late toxicity after peposertib-enhanced chemoradiation in rectal cancer patients managed with organ preservationW Zambare, R Ravella, C Li, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Paired primary-metastasis patient-derived organoids and mouse models identify phenotypic evolution and druggable dependencies of peritoneal metastasis from appendiceal cancerAhmed Mahmoud, Philip H Choi, Christine Sukhwa, et al.
Journal of Medicinal Chemistry|November 30, 2004
Identification of a small molecule nonpeptide active site beta-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteasesCraig A Coburn, Shawn J Stachel, Yue-Ming Li, et al.
JAMA Oncology|March 23, 2018
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal CancerAndrea Cercek, Campbell S D Roxburgh, Paul Strombom, et al.
Pageof 61